These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24204895)

  • 1. Vaccination against foot-and-mouth disease: do initial conditions affect its benefit?
    Porphyre T; Auty HK; Tildesley MJ; Gunn GJ; Woolhouse ME
    PLoS One; 2013; 8(10):e77616. PubMed ID: 24204895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of foot-and-mouth disease (FMD) vaccination on virus transmission and the significance for the field.
    Orsel K; Bouma A
    Can Vet J; 2009 Oct; 50(10):1059-63. PubMed ID: 20046605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations for design and implementation of vaccine field trials for novel foot-and-mouth disease vaccines.
    Lyons NA; Knight-Jones TJD; Bartels C; Paton DJ; Ferrari G; Vermillion MS; Brooks AW; Motroni R; Parker E; Hefferin Berquist ML; Sumption KJ; Klement E
    Vaccine; 2019 Feb; 37(8):1007-1015. PubMed ID: 30685245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies I: Benefits of Higher Potency Vaccines and Associated NSP DIVA Test Systems in Post-Outbreak Surveillance.
    Barnett PV; Geale DW; Clarke G; Davis J; Kasari TR
    Transbound Emerg Dis; 2015 Aug; 62(4):367-87. PubMed ID: 24112127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit-cost analysis of vaccination and preemptive slaughter as a means of eradicating foot-and-mouth disease.
    Bates TW; Carpenter TE; Thurmond MC
    Am J Vet Res; 2003 Jul; 64(7):805-12. PubMed ID: 12856762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies II: Waiting Periods After Emergency Vaccination in FMD Free Countries.
    Geale DW; Barnett PV; Clarke GW; Davis J; Kasari TR
    Transbound Emerg Dis; 2015 Aug; 62(4):388-406. PubMed ID: 24131661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling vaccination strategies against foot-and-mouth disease.
    Keeling MJ; Woolhouse ME; May RM; Davies G; Grenfell BT
    Nature; 2003 Jan; 421(6919):136-42. PubMed ID: 12508120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing vaccines against foot-and-mouth disease and some other exotic viral diseases of livestock.
    Paton DJ; Taylor G
    Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2774-81. PubMed ID: 21893540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critically appraised topic: the use of vaccination to control the spread of foot-and-mouth disease in Australian livestock in the event of an incursion.
    Humphries B; Ward MP
    Aust Vet J; 2024 Aug; 102(8):407-415. PubMed ID: 38840308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of stakeholders influence, geographic level and risk perception on strategic decisions in simulated foot and mouth disease epizootics in France.
    Marsot M; Rautureau S; Dufour B; Durand B
    PLoS One; 2014; 9(1):e86323. PubMed ID: 24466024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a high performance liquid chromatography method for quantitation of foot-and-mouth disease virus antigen in vaccines and vaccine manufacturing.
    Spitteler MA; Romo A; Magi N; Seo MG; Yun SJ; Barroumeres F; Régulier EG; Bellinzoni R
    Vaccine; 2019 Aug; 37(36):5288-5296. PubMed ID: 31353259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the benefit of emergency vaccination in a foot-and-mouth disease free country with low livestock density.
    Dürr S; Fasel-Clemenz C; Thür B; Schwermer H; Doherr MG; Dohna HZ; Carpenter TE; Perler L; Hadorn DC
    Prev Vet Med; 2014 Jan; 113(1):34-46. PubMed ID: 24211105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing control strategies against foot-and-mouth disease: will vaccination be cost-effective in Denmark?
    Boklund A; Halasa T; Christiansen LE; Enøe C
    Prev Vet Med; 2013 Sep; 111(3-4):206-19. PubMed ID: 23791121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foot-and-mouth disease vaccines.
    Diaz-San Segundo F; Medina GN; Stenfeldt C; Arzt J; de Los Santos T
    Vet Microbiol; 2017 Jul; 206():102-112. PubMed ID: 28040311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
    Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
    Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination against foot-and-mouth disease I: epidemiological consequences.
    Backer JA; Hagenaars TJ; Nodelijk G; van Roermund HJ
    Prev Vet Med; 2012 Nov; 107(1-2):27-40. PubMed ID: 22749763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the benefits of vaccination when used in combination with stamping-out measures against hypothetical introductions of foot-and-mouth disease into New Zealand: a simulation study.
    Sanson RL; Rawdon T; Owen K; Hickey K; van Andel M; Yu ZD
    N Z Vet J; 2017 May; 65(3):124-133. PubMed ID: 27870922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspects of emergency vaccination against foot-and-mouth disease.
    Barnett P; Garland AJ; Kitching RP; Schermbrucker CG
    Comp Immunol Microbiol Infect Dis; 2002 Oct; 25(5-6):345-64. PubMed ID: 12365810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ring vaccination against foot-and-mouth disease.
    Tom B; Moutou F; Dufour B; Durand B
    Comp Immunol Microbiol Infect Dis; 2002 Oct; 25(5-6):365-72. PubMed ID: 12365811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination against foot-and-mouth disease: the implications for Canada.
    Kahn S; Geale DW; Kitching PR; Bouffard A; Allard DG; Duncan JR
    Can Vet J; 2002 May; 43(5):349-54. PubMed ID: 12001500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.